ABCC7 p.Ser737Ala
[switch to full view]Comments [show]
None has been submitted yet.
PMID: 11053017
[PubMed]
Baldursson O et al: "Contribution of R domain phosphoserines to the function of CFTR studied in Fischer rat thyroid epithelia."
No.
Sentence
Comment
14
Changing Ser737 to alanine increased current above wild-type levels, suggesting that phosphorylation of Ser737 may inhibit current in wild-type CFTR.
X
ABCC7 p.Ser737Ala 11053017:14:9
status: NEW56 In each of the serine to alanine mutants, S660A, S737A, S795A, and S813A, alanine replaced serine at the designated residue.
X
ABCC7 p.Ser737Ala 11053017:56:49
status: NEW108 The S795A channels generated more current, but it was still less than that produced by wild-type CFTR. Interestingly, current from the S737A variant tended to be greater than that of wild-type CFTR, although the difference was not significant.
X
ABCC7 p.Ser737Ala 11053017:108:135
status: NEW114 Current from the S795A variant was not different from that in wild-type CFTR. Interestingly, current generated by the S737A variant was more than twice that generated by wild-type CFTR.
X
ABCC7 p.Ser737Ala 11053017:114:118
status: NEW134 The S737A variant generated more current than the wild type, and the S-Quad-A mutant generated less.
X
ABCC7 p.Ser737Ala 11053017:134:4
status: NEW137 The data show that the S-Quad-A variant was less sensitive to forskolin than the wild type and that the S737A variant was more sensitive than wild-type CFTR.
X
ABCC7 p.Ser737Ala 11053017:137:104
status: NEW140 The results show that current increased more rapidly with S737A than with wild-type and S-Quad-A CFTR.
X
ABCC7 p.Ser737Ala 11053017:140:58
status: NEW152 The increase in current and the more rapid activation observed when Ser737 was mutated to alanine suggested that phosphorylation of Ser737 may inhibit current.
X
ABCC7 p.Ser737Ala 11053017:152:68
status: NEW157 Activation by increasing concentrations of forskolin of Cl- current in epithelia expressing wild-type CFTR, S737A, and SQuad-A.
X
ABCC7 p.Ser737Ala 11053017:157:108
status: NEW161 C: current in epithelia expressing wild-type CFTR, S737A, and S-Quad-A in response to forskolin.
X
ABCC7 p.Ser737Ala 11053017:161:51
status: NEW187 Time course of Cl- current activation in epithelia expressing wild-type CFTR, S737A, and S-Quad-A.
X
ABCC7 p.Ser737Ala 11053017:187:78
status: NEW225 A particularly striking example is the different function of S737A in cells and in excised membrane patches.
X
ABCC7 p.Ser737Ala 11053017:225:61
status: NEW226 In FRT cells and in Xenopus oocytes (28), Ser737 generated more current than wild-type CFTR, but, in patches, S737A showed the same open state probability as the wild type, and the sensitivity to ATP was reduced (29).
X
ABCC7 p.Ser737Ala 11053017:226:110
status: NEW
PMID: 11244086
[PubMed]
Ostedgaard LS et al: "Regulation of the cystic fibrosis transmembrane conductance regulator Cl- channel by its R domain."
No.
Sentence
Comment
35
In excised, cell-free patches, the S737A mutant reduced Po (20), but in Xenopus oocytes and epithelia, the S737A mutant increased cAMP-stimulated current (21, 23).
X
ABCC7 p.Ser737Ala 11244086:35:35
status: NEWX
ABCC7 p.Ser737Ala 11244086:35:107
status: NEW
PMID: 15155835
[PubMed]
Ai T et al: "Capsaicin potentiates wild-type and mutant cystic fibrosis transmembrane conductance regulator chloride-channel currents."
No.
Sentence
Comment
142
We further explored the action of capsaicin using CFTR mutants whose eight major PKA consensus serines are substituted with alanine (S660A, S686A, S700A, S712A, S737A, S768A, S795A, and S813A), so called S-oct-A or 8SA.
X
ABCC7 p.Ser737Ala 15155835:142:161
status: NEW
PMID: 15657296
[PubMed]
Csanady L et al: "Preferential phosphorylation of R-domain Serine 768 dampens activation of CFTR channels by PKA."
No.
Sentence
Comment
208
In addition, to verify the inferred link between the major mobility shift of the R domain and phosphorylation of Ser 737 (Fig. 2), the other candidate inhibitory serine (Wilkinson et al., 1997), we studied phosphorylation of His-tagged R-domain proteins containing the single mutation S737A, or the double mutation S737A-S768A.
X
ABCC7 p.Ser737Ala 15657296:208:285
status: NEWX
ABCC7 p.Ser737Ala 15657296:208:315
status: NEW209 The incremental mobility shifts already seen in Figs. 1 and 2 as phosphorylation of the R domain progressed were recapitulated in the His-tagged WT peptide (Fig. 8 A), and were not substantially altered by the S768A mutation in either the WT or S737A background (Fig. 8, B and D vs. A and C).
X
ABCC7 p.Ser737Ala 15657296:209:245
status: NEW210 As anticipated, however, the S737A mutation abolished the large mobility shift of both WT and S768A R-domain peptides (Fig. 8, C and D vs. A and B).
X
ABCC7 p.Ser737Ala 15657296:210:29
status: NEW217 WT (A) and mutant R-domain peptides, with Ser768 replaced by alanine (S768A; B), Ser737 replaced by alanine (S737A; C), or Ser737 and Ser768 both replaced by alanine (S737A-S768A; D), were phosphorylated with 10 nM PKA and 5 M ␥32P-MgATP for 0.5-60 min as indicated.
X
ABCC7 p.Ser737Ala 15657296:217:81
status: NEWX
ABCC7 p.Ser737Ala 15657296:217:109
status: NEWX
ABCC7 p.Ser737Ala 15657296:217:167
status: NEW219 The major mobility shift (to band 3; Figs. 1 and 2) was seen in the WT and S768A peptides, but not in the S737A or S737A-S768A peptides.
X
ABCC7 p.Ser737Ala 15657296:219:106
status: NEWX
ABCC7 p.Ser737Ala 15657296:219:115
status: NEW296 Mass spectrometry and site-directed mutagenesis revealed that the major mobility shift was linked to phosphorylation of Ser 737 both at low and high [MgATP] (Fig. 2), and this requirement was confirmed by the absence of the large mobility shift after mutation of Ser 737 to Ala in either WT or S768A R-domain peptide (Fig. 8, A-D; see also Borchardt et al., 1996; Kole et al., 1998).
X
ABCC7 p.Ser737Ala 15657296:296:263
status: NEW299 Though we did not examine its consequences for channel gating, the S737A mutation has been reported to leave burst duration unchanged from that of WT CFTR (Winter and Welsh, 1997), whereas we found the S768A mutation to roughly double burst duration (Fig. 6).
X
ABCC7 p.Ser737Ala 15657296:299:67
status: NEW
No.
Sentence
Comment
78
Substitutionofalanine for phosphorylatable S737A or S768A enhanced the channel activity, suggesting that phosphorylation at either of these sites may inhibit phosphorylation of other stimulatory sites[72] .
X
ABCC7 p.Ser737Ala 17700961:78:43
status: NEW
No.
Sentence
Comment
43
EXPERIMENTAL PROCEDURES cRNAs for CFTR and Double Electrode Voltage Clamp-Oocytes were injected with cRNA (10 ng, 47 nl of double-distilled water) encoding wtCFTR, L1430A/L1431A, S573A, S1248A, F508del-CFTR, G551D-CFTR, S768A, S737A, S768D, S737D, E1474X, and AMPK␣1.
X
ABCC7 p.Ser737Ala 19095655:43:227
status: NEW93 Fig. 2B demonstrates that AMPK indeed phosphorylates the R domain in vitro and this AMPK phosphorylation is largely reduced in R domain mutants S737A and S768A (compare lanes 2 and 3 in Fig. 2B, lower panel).
X
ABCC7 p.Ser737Ala 19095655:93:144
status: NEW94 The data also suggest that serine 768 has a much greater reductive impact because S768A almost abolished all the phosphorylation, whereas some were preserved with S737A.
X
ABCC7 p.Ser737Ala 19095655:94:163
status: NEW96 We quantified data (supplemental Fig. S2) from three independent experiments and found that the S737A mutation leads to a small 23 Ϯ 8% reduction in counts, whereas S768A leads to a major 81 Ϯ 5% (mean Ϯ range) reduction similar to the double mutant (87% Ϯ 4%) when compared with the wild type (100%).
X
ABCC7 p.Ser737Ala 19095655:96:96
status: NEW125 It is clear that S768A (lower left panel) has a more profound inhibitory effect on R domain phosphorylation compared with S737A (upper right) given that all these experiments were run simultaneously with similar concentrations of R domain protein and kinase, and each imaged for identical lengths of time.
X
ABCC7 p.Ser737Ala 19095655:125:122
status: NEW126 Broadly, prolonged incubation that previously created two major spots found with AMPK alone was now supplemented by multiple small spots that almost disappeared after S768A mutation, but much less so after S737A mutation (Fig. 2D, compare lower two panels with upper).
X
ABCC7 p.Ser737Ala 19095655:126:206
status: NEW128 When expressed in oocytes, CFTR bearing the R domain mutants S737A and S768A as well as the double mutant S737A/ S768A (Fig. 3A) produced dramatically enhanced conductances (S768A Ͼ S737A; Fig. 3B) upon stimulation with forskolin (2 M) and IBMX (1 mM).
X
ABCC7 p.Ser737Ala 19095655:128:61
status: NEWX
ABCC7 p.Ser737Ala 19095655:128:106
status: NEWX
ABCC7 p.Ser737Ala 19095655:128:188
status: NEW130 The large Cl-conductances generated by S737A/S768A were inhibited by 5 M of the specific chloride channel blocker CFTRinh-172 (Fig. 3D), or alternatively, the PKA inhibitor KT5720 and Cl- replacement by gluconate (not shown).
X
ABCC7 p.Ser737Ala 19095655:130:39
status: NEW131 Once again the differential roles of these two serines were observed because the conductance observed with S737A was almost 100 S lower than that found with S768A.
X
ABCC7 p.Ser737Ala 19095655:131:107
status: NEW135 B, phosphoryl- ationoftheRdomainwithPKAandAMPK.AMPKphosphorylationwaslargely reduced or abolished in S737A and S768A, respectively (lower panel).
X
ABCC7 p.Ser737Ala 19095655:135:101
status: NEW146 Overall the data suggest that S737A, S768A, and the double mutant S737A/ S768A were no longer sensitive to stimulation or inhibition of AMPK indicating that phosphorylation at both serines is required (Fig. 3C, middle panels).
X
ABCC7 p.Ser737Ala 19095655:146:30
status: NEWX
ABCC7 p.Ser737Ala 19095655:146:66
status: NEW151 In contrast to wtCFTR the CFTR mutants S737A (not shown), S768A, and S737A/S768A produced a high Cl- con- ductance under basal conditions, i.e. in the absence of IBMX and forskolin (Fig. 4, A and B).
X
ABCC7 p.Ser737Ala 19095655:151:39
status: NEWX
ABCC7 p.Ser737Ala 19095655:151:69
status: NEW155 A, whole cell currents activated by IBMX (1 mM) and forskolin (2 M) in wtCFTR and S737A/ S768A-CFTRexpressingoocytes.B,summaryofwholecellconductancesgen- erated by wtCFTR and different CFTR mutants.
X
ABCC7 p.Ser737Ala 19095655:155:90
status: NEW156 C, summary of CFTR whole cell conductances generated by wtCFTR and different CFTR mutants, and effects of phenformin and compound C. D, summary of the whole cell conductance activated by S737A/S768A-CFTR and inhibition by the CFTR blocker CFTRinh-172.
X
ABCC7 p.Ser737Ala 19095655:156:187
status: NEW161 S737A/S768A-CFTR generates a baseline conductance.
X
ABCC7 p.Ser737Ala 19095655:161:0
status: NEW162 A, effect of extracellular Cl- replacement by gluconate (glcn) on whole cell currents generated by wtCFTR, S768A-CFTR, and S737A/S768A-CFTR in the absence of IBMX and forskolin.
X
ABCC7 p.Ser737Ala 19095655:162:123
status: NEW164 C, summary of the whole cell conductances generated by wtCFTR and S737A/S768A-CFTRintheabsenceofstimulationwithIBMXandforskolinand effectsofphenformin,compoundC,andCFTRinh-172.DandE,baselinewhole cell conductances generated by wild type CFTR (D) and S737A/S768A-CFTR (E) and effects of compound C and the PKA inhibitor KT520.
X
ABCC7 p.Ser737Ala 19095655:164:66
status: NEWX
ABCC7 p.Ser737Ala 19095655:164:250
status: NEW170 Moreover, the PKA inhibitor KT5720 (50 M) inhibited this enhanced baseline CFTR conductance generated by S737A/ S768A irrespective of the presence of compound C (Fig. 4E).
X
ABCC7 p.Ser737Ala 19095655:170:113
status: NEW172 We interpret this finding to suggest that the sensitivity of S737A/ S768A-CFTR toward PKA inhibition is retained, which implies that PKA is now active after the loss of AMPK sensitivity.
X
ABCC7 p.Ser737Ala 19095655:172:61
status: NEW178 The initial recovery from PKA stimulation was equal in S737A/ S768A (1.1 Ϯ 0.3 S/min) and wtCFTR (1.1 Ϯ 0.1 S/min) (Fig. 5C), but was enhanced in ooctyes coexpressing kinase-dead AMPK␣1-K45R (2.8 Ϯ 0.4 S/min), whereas overexpression of wtAMPK␣1beta1␥1 literally eliminated CFTR currents (Fig. 5B).
X
ABCC7 p.Ser737Ala 19095655:178:55
status: NEW180 Although AMPK largely antagonizes activation of CFTR, the mutated serines S737A and S768A do not seem to influence the recovery time from forskolin stimulation.
X
ABCC7 p.Ser737Ala 19095655:180:74
status: NEW210 C, inactivation of conductances generated by wtCFTR and S737A/S768A-CFTR.
X
ABCC7 p.Ser737Ala 19095655:210:56
status: NEW225 Even maximal stimulation of wtCFTR with a mixture of 8-Br- - cAMP, IBMX, and forskolin does not produce the same high level of conductance as S737A-CFTR or S768A-CFTR.
X
ABCC7 p.Ser737Ala 19095655:225:142
status: NEW
PMID: 20952391
[PubMed]
Wang G et al: "State-dependent regulation of cystic fibrosis transmembrane conductance regulator (CFTR) gating by a high affinity Fe3+ bridge between the regulatory domain and cytoplasmic loop 3."
No.
Sentence
Comment
162
Although Fig. 4E indicates that both S768A and S737A mutants were much inhibited by Fe3ϩ , these sites may not be excluded as Fe3ϩ ligands.
X
ABCC7 p.Ser737Ala 20952391:162:47
status: NEW180 Unlike S768A, S737A exhibited a weak DTT effect (Fig. 6D), suggesting that phosphorylated Ser-737 may not participate in Fe3ϩ binding.
X
ABCC7 p.Ser737Ala 20952391:180:14
status: NEW
PMID: 21059651
[PubMed]
Wang G et al: "The inhibition mechanism of non-phosphorylated Ser768 in the regulatory domain of cystic fibrosis transmembrane conductance regulator."
No.
Sentence
Comment
143
In contrast, curcumin had no such effect on S737A and H954A mutants, suggesting that they may be weak inhibitory residues, although disulfide cross-linking of S737C to H954C strongly inhibited channel activity (Figs. 2E and 4E).
X
ABCC7 p.Ser737Ala 21059651:143:44
status: NEW144 Because curcumin increased initial channel activity of most mutants at the R-CL3 interface after ATP was present, it is reasonable that subsequent PKA dependence was greatly reduced except for S737A and H954A.
X
ABCC7 p.Ser737Ala 21059651:144:193
status: NEW234 Error bars, S.E. TABLE 1 Potential roles in hydrogen bonding at the CL3-R domain interface Note that mutants whose channel activity was increased by curcumin in the presence of ATP are highlighted in boldface type. Residues Role in H-bond Mutants Arg Strong donor H950R, S768R, H950R/S768R, H950R/S768D, H950D/S768R Asp Strong acceptor H950D, S768D, H950D/S768D, H950R/S768D, H950D/S768R Thr, Gln, Ser, His Donor/Acceptor H950Q, S768T, WT Ala Negative control K946A, H950A, K951A, H954A, S955A, Q958A, S737A, S768A, ⌬R Inhibition of CFTR by Ser768 JANUARY 21, 2011•VOLUME 286•NUMBER 3 JOURNAL OF BIOLOGICAL CHEMISTRY 2177 matter whether cAMP was present or not in the extracellular perfusate.
X
ABCC7 p.Ser737Ala 21059651:234:502
status: NEW311 In contrast, the S737A mutation failed to promote channel opening by ATP and curcumin, although it was also closed to CL3 (Figs. 2-4).
X
ABCC7 p.Ser737Ala 21059651:311:17
status: NEW
PMID: 21455600
[PubMed]
Siwiak M et al: "Structural models of CFTR-AMPK and CFTR-PKA interactions: R-domain flexibility is a key factor in CFTR regulation."
No.
Sentence
Comment
121
However, experiments [7] have shown an 80% decrease in AMPK phosphorylation for the CFTR double mutant S737A-S768A.
X
ABCC7 p.Ser737Ala 21455600:121:103
status: NEW156 This shows that, at the molecular level, it is possible that 20% of the currently unexplained phosphorylation signal observed in the CFTR double mutant S737A-S768A incubated with AMPK may come from "activator" serines such as S813.
X
ABCC7 p.Ser737Ala 21455600:156:152
status: NEW155 This shows that, at the molecular level, it is possible that 20% of the currently unexplained phosphorylation signal observed in the CFTR double mutant S737A-S768A incubated with AMPK may come from "activator" serines such as S813.
X
ABCC7 p.Ser737Ala 21455600:155:152
status: NEW
PMID: 19328185
[PubMed]
Hegedus T et al: "Role of individual R domain phosphorylation sites in CFTR regulation by protein kinase A."
No.
Sentence
Comment
132
On the other hand, the much lower rate of S813 phosphorylation appeared to be reduced somewhat further by either the S700A or S737A substitutions, but not by the S768A substitution.
X
ABCC7 p.Ser737Ala 19328185:132:126
status: NEW152 Membranes isolated from BHK cells expressing S700A (A), S737A (B), S768A (C), or S813A (D) were subjected to phosphorylation for 0, 2, 4, 8, 16, 32, and 64 min.
X
ABCC7 p.Ser737Ala 19328185:152:56
status: NEW242 The S737A and S768A constructs exhibit slightly higher basal open probability (Po =0.06) compared to wild type (Po ≪0.01) in good agreement with data of Csanady et al. [24].
X
ABCC7 p.Ser737Ala 19328185:242:4
status: NEW245 The channel properties of the S737A mutant were previously reported to be very similar to those of the wild type by Wilkinson et al. [10].
X
ABCC7 p.Ser737Ala 19328185:245:30
status: NEW131 On the other hand, the much lower rate of S813 phosphorylation appeared to be reduced somewhat further by either the S700A or S737A substitutions, but not by the S768A substitution.
X
ABCC7 p.Ser737Ala 19328185:131:126
status: NEW151 Membranes isolated from BHK cells expressing S700A (A), S737A (B), S768A (C), or S813A (D) were subjected to phosphorylation for 0, 2, 4, 8, 16, 32, and 64 min.
X
ABCC7 p.Ser737Ala 19328185:151:56
status: NEW241 The S737A and S768A constructs exhibit slightly higher basal open probability (Po =0.06) compared to wild type (Po âa;0.01) in good agreement with data of Csanady et al. [24].
X
ABCC7 p.Ser737Ala 19328185:241:4
status: NEW244 The channel properties of the S737A mutant were previously reported to be very similar to those of the wild type by Wilkinson et al. [10].
X
ABCC7 p.Ser737Ala 19328185:244:30
status: NEW
PMID: 18423665
[PubMed]
Hegedus T et al: "Computational studies reveal phosphorylation-dependent changes in the unstructured R domain of CFTR."
No.
Sentence
Comment
28
Replacement of serine with alanine at position 737 or 768 was reported to produce a channel with a higher level of activity in both the non-phosphorylated and phosphorylated state.16,19-21 These studies led to the indirect conclusion that these two sites are inhibitory in their phosphorylated state.
X
ABCC7 p.Ser737Ala 18423665:28:15
status: NEW27 Replacement of serine with alanine at position 737 or 768 was reported to produce a channel with a higher level of activity in both the non-phosphorylated and phosphorylated state.16,19-21 These studies led to the indirect conclusion that these two sites are inhibitory in their phosphorylated state.
X
ABCC7 p.Ser737Ala 18423665:27:15
status: NEW
PMID: 9305845
[PubMed]
Winter MC et al: "Stimulation of CFTR activity by its phosphorylated R domain."
No.
Sentence
Comment
162
Mutation of the individual serines reduced Po, but to different extents: the S795A mutation had the largest effect and S737A had little or no effect in the presence of 1 mM ATP (Fig. 3a, b).
X
ABCC7 p.Ser737Ala 9305845:162:119
status: NEW185 Number of experiments for b/c and d were: 17/6 for wild-type (WT), 8 for wild-type (-PKA), 8/7 for S660A, 5/5 for S737A, 8/6 for S795A, 9/7 for S813A, and 11/4 for S-Quad-A.
X
ABCC7 p.Ser737Ala 9305845:185:114
status: NEW188 0.0 0.1 0.2 0.3 0.4 0.5 0.6 Po 0 0.2 0.4 0.6 0.8 1 10 [ATP] (mM) S813A S795A S737A S660A WT (-PKA) WT Figure 4 Effect of ATP concentration on Po of CFTR containing phosphorylation site mutations.
X
ABCC7 p.Ser737Ala 9305845:188:77
status: NEW
PMID: 9252549
[PubMed]
Wilkinson DJ et al: "CFTR activation: additive effects of stimulatory and inhibitory phosphorylation sites in the R domain."
No.
Sentence
Comment
15
In contrast, alanine substitution at serine-737 or -768 actually decreased the KA for activation, suggesting that phosphorylation at either of these sites is inhibitory.
X
ABCC7 p.Ser737Ala 9252549:15:13
status: NEW87 S686A 0.75 ?I 0.07 9 N PKC site S700A 0.86 t 0.07* 12 S ++ +++ S712A 0.67 t 0.12 9 N - ++ S737A 0.35 5 0.05* 8 I +++ +++ S768A 0.09 IT 0.03* 8 I - ++++ S795A 1.24 + 0.22* 9 S +++ ++++ S813A 3.18-+0.36* 6 S ++++ ++ Values of half-maximal inhibition constant for activation (KA) are means + SE by 3-isobutyl-1-methylxanthine (IBMX) obtained for wild-type cystic fibrosis transmembrane conductance regulator (CFTR) and variants with single serine-to-alanine substitutions.
X
ABCC7 p.Ser737Ala 9252549:87:90
status: NEW107 Symbols show averaged IBMX dose-response data for wild-type CFTR and several single-site serine-to-alanine mutants (S660A, S737A, S768A, S795A, and S813A).
X
ABCC7 p.Ser737Ala 9252549:107:123
status: NEW
PMID: 7690753
[PubMed]
Rich DP et al: "Regulation of the cystic fibrosis transmembrane conductance regulator Cl- channel by negative charge in the R domain."
No.
Sentence
Comment
48
Mutants are named by the number of the amino acid residue preceded by the wild-type amino acid and followed bythe aminoacid to which the residue was changed using the single-letter aminoacid code; for example,inthemutant CFTR S66OA,S737A,S795A,S813A (also called CFTR S-Quad-A for convenience), alanines are substituted for serines at amino acid positions 660, 737, 795, and 813.
X
ABCC7 p.Ser737Ala 7690753:48:232
status: NEW66 In vivo phosphorylation ofwild-typeand mutant CFTR CFTR S-Quad-A (S66OA,S737A,S795A,S813A), or CFTR S-Oct-A (S660A,S686A,S700A,S712A,S737A,S768A,S795A,S813A) weretran- siently expressed in HeLa cells.
X
ABCC7 p.Ser737Ala 7690753:66:72
status: NEWX
ABCC7 p.Ser737Ala 7690753:66:133
status: NEW89 Functional assay of CFTR S-Quad-Aby SPQ fluorescence.The changein SPQfluorescenceis shown for HeLa cellsexpress- ing wild-type CFTR (n = 53, where n = number of cells) or CFTR S-Quad-A tS660A,S737A,S795A,S813A)(n = 53) and for virus only- infectedcells(no plasmid) as a negative control (n = 47).
X
ABCC7 p.Ser737Ala 7690753:89:191
status: NEW94 Single-channelanalysis of gle-channel traces from an excised, in-cell expressing CFTR S-Quad-A side-out membrane patch from a HeLa (S660A,S737A,S795A,S813A).Each trace is about 14s long.
X
ABCC7 p.Ser737Ala 7690753:94:138
status: NEW109 RESULTS Serine-to-Alanine Substitutionsin the R Domain Do NotAbolish CFTR Cl- Channel Activity-& a firststep to address the possibility that additional PKA phosphorylation sites might regulate CFTR, we asked whether the S-Quad-A (S660A,S737A,S795A,S813A) mutant could still bephosphorylated in vivofollowing CAMPstimulation.
X
ABCC7 p.Ser737Ala 7690753:109:236
status: NEW121 The single-channel open-stateprobabil- ity for wild-type CFTR (n = 14), CFTR S-Quad-A (S600A,S737A, S712A,S737A,S768A,S795A,S813A) (n = 7), or CFTR S-Oct-D (S660D,S686D,S700D,S712D,S737D,S768D,S795D,S813D)(n = 7in ATP alone (-PKA);n = 10 inPKA and ATP (+PkX))C1-channels was determined as described under "Experimental Procedures."
X
ABCC7 p.Ser737Ala 7690753:121:93
status: NEWX
ABCC7 p.Ser737Ala 7690753:121:106
status: NEW123 S795A,S813A) (n = 5).
X
ABCC7 p.Ser737Ala 7690753:123:93
status: NEWX
ABCC7 p.Ser737Ala 7690753:123:106
status: NEW139 CFTR (A) or CFTR S-Quad-A (S660A,S737A,S795A,S813A)( B )were transiently expressed inCOS-7 cells.
X
ABCC7 p.Ser737Ala 7690753:139:33
status: NEW174 Fig. 1lA shows that simultaneous substitutionof the four in vivo PKA sites with aspartates (in the S-Quad-D mutant) did not generate constitutively active CFTR C1-channels as assessed by the SPQ fluorescence assay: the mutant channels opened only after stimulation by CAMP.We observed similar results withCFTR S-Quint-D which contained substitutionsof A MockS-Hept-A C S-OCt-A transfected (A) or were transfected with pMT-CFTR S-Hept-A (S660A,S686A,S700A,S712A,S737A,S768A,S795A) (B)or pMT-CFl`R S-Oct-A FIG.9.
X
ABCC7 p.Ser737Ala 7690753:174:461
status: NEW176 COS-7 cells were mock- (S660A,S686A,S700A,S712A,S737A,S768A,S795A,S813A)(C).
X
ABCC7 p.Ser737Ala 7690753:176:48
status: NEW47 Mutants are named by the number of the amino acid residue preceded by the wild-type amino acid and followed bythe aminoacid to which the residue was changed using the single-letter amino acid code; for example,inthemutant CFTR S66OA,S737A,S795A,S813A (also called CFTR S-Quad-A for convenience), alanines are substituted for serines at amino acid positions 660, 737, 795, and 813.
X
ABCC7 p.Ser737Ala 7690753:47:233
status: NEW65 In vivo phosphorylation ofwild-typeand mutant CFTR CFTR S-Quad-A (S66OA,S737A,S795A,S813A), or CFTR S-Oct-A (S660A,S686A,S700A,S712A,S737A,S768A,S795A,S813A) were transiently expressed in HeLa cells.
X
ABCC7 p.Ser737Ala 7690753:65:72
status: NEWX
ABCC7 p.Ser737Ala 7690753:65:133
status: NEW95 Single-channelanalysis of gle-channel traces from an excised, in-cell expressing CFTR S-Quad-A side-out membrane patch from a HeLa (S660A,S737A,S795A,S813A).Each trace is about 14s long.
X
ABCC7 p.Ser737Ala 7690753:95:138
status: NEW111 RESULTS Serine-to-Alanine Substitutions in the R Domain Do NotAbolish CFTR Cl-Channel Activity-& a firststep to address the possibility that additional PKA phosphorylation sites might regulate CFTR, we asked whether the S-Quad-A (S660A,S737A,S795A,S813A) mutant could still be phosphorylated in vivofollowing CAMPstimulation.
X
ABCC7 p.Ser737Ala 7690753:111:236
status: NEW142 CFTR (A) or CFTR S-Quad-A (S660A,S737A,S795A,S813A) ( B )were transiently expressed inCOS-7 cells.
X
ABCC7 p.Ser737Ala 7690753:142:33
status: NEW178 Fig. 1lA shows that simultaneous substitution of the four in vivo PKA sites with aspartates (in the S-Quad-D mutant) did not generate constitutively active CFTR C1-channels as assessed by the SPQ fluorescence assay: the mutant channels opened only after stimulation by CAMP.We observed similar results withCFTR S-Quint-D which contained substitutionsof A Mock S-Hept-A C S-OCt-A transfected (A) or were transfected with pMT-CFTR S-Hept-A (S660A,S686A,S700A,S712A,S737A,S768A,S795A) (B) or pMT-CFl`R S-Oct-A FIG. 9.
X
ABCC7 p.Ser737Ala 7690753:178:463
status: NEW180 COS-7 cells were mock- (S660A,S686A,S700A,S712A,S737A,S768A,S795A,S813A) (C).
X
ABCC7 p.Ser737Ala 7690753:180:48
status: NEW
PMID: 7684377
[PubMed]
Chang XB et al: "Protein kinase A (PKA) still activates CFTR chloride channel after mutagenesis of all 10 PKA consensus phosphorylation sites."
No.
Sentence
Comment
7
A previous investigationconcluded thatactivationby PKA is crit- icallydependent on phosphorylation at four of the nine predicted PKA sites in the R domain (S660A, S737A, S795A,SS13A), becausea "Quad"mutant lacking these sites couldnotbeactivated.
X
ABCC7 p.Ser737Ala 7684377:7:163
status: NEW37 The following mutations were introduced into CFTR, S422A (TCT to GCT), S660A (TCA to GCA), S686A (TCT to GCT), S700A (TCT toGCT), S712A (TCC to GCC), S737A (TCC to GCC), S768A (TCT toGCT), T788A (ACAto GCA),S795A (TCA to GCA), S813A (TCA to GCA), S660E (TCA to GAA),S737E (TCC to GAG), S795E (TCA to GAA), and S813E (TCA to GAA).
X
ABCC7 p.Ser737Ala 7684377:37:150
status: NEW39 The counterparts of CFTR cDNA in pUCF2.5 were replaced by PCR- mutated versions by interchange of the following fragments, S660A, DraIIIIEcoRI fragment, S737A, EcoRIIHpaIfragment, S795A and S813A,StyIIStyI fragment(Fig. 1A).
X
ABCC7 p.Ser737Ala 7684377:39:153
status: NEW40 A mutant containing S660/737/ 795/813A (pUCF2.5/4SA) was assembled by replacing the counterparts of a plasmid containing S795/813A with the DraIII/EcoRI fragment (S660A) and EcoRI/HpaI fragment (S737A).
X
ABCC7 p.Ser737Ala 7684377:40:195
status: NEW
PMID: 23760269
[PubMed]
Billet A et al: "Role of tyrosine phosphorylation in the muscarinic activation of the cystic fibrosis transmembrane conductance regulator (CFTR)."
No.
Sentence
Comment
102
Carbachol Stimulates CFTR through PKA and Non-PKA Signaling Pathways-To explore PKA-independent regulation of CFTR without using inhibitors that might have confounding effects on other pathways, we studied the activation of 15SA-CFTR (S422A/S660A/S670A/S686A/T690A/S700A/S712A/ S737A/S753A/S768A/T787A/T788A/S790A/S795A/S813A).
X
ABCC7 p.Ser737Ala 23760269:102:278
status: NEW
PMID: 24727471
[PubMed]
Luz S et al: "LMTK2-mediated phosphorylation regulates CFTR endocytosis in human airway epithelial cells."
No.
Sentence
Comment
8
Compared with the wild-type CFTR, the phosphorylation-deficient mutant CFTR-S737A shows increased cell surface density and decreased endocytosis.
X
ABCC7 p.Ser737Ala 24727471:8:76
status: NEW203 To demonstrate specificity of the phosphosite antibody, parental CFBE41o-cells were transiently transfected with WT-CFTR or CFTR with the S737A substitution (CFTR-S737A) inactivating the phosphorylation site (31).
X
ABCC7 p.Ser737Ala 24727471:203:138
status: NEWX
ABCC7 p.Ser737Ala 24727471:203:163
status: NEW204 Even with calyculin A treatment of the cells, the CFTR-S737A mutant was not detected by antibody Ab-737, unlike the WT-CFTR (Fig. 5B).
X
ABCC7 p.Ser737Ala 24727471:204:55
status: NEW233 B, parental CFBE41o-cells were transfected with the WT-CFTR (WT) or the mutant CFTR-S737A (S737A).
X
ABCC7 p.Ser737Ala 24727471:233:84
status: NEWX
ABCC7 p.Ser737Ala 24727471:233:91
status: NEW234 Unlike the WT-CFTR, the CFTR-S737A was not detected by the antibody Ab-737 in WCL.
X
ABCC7 p.Ser737Ala 24727471:234:29
status: NEW287 The Phosphorylation-deficient CFTR-S737A Mutant is More Abundant at the Plasma Membrane Due to Decreased Endocytosis-If the LMTK2 mediated phosphorylation of CFTR-Ser737 induces CFTR endocytosis, eliminating the phosphorylation site by the S737A substitution should reduce CFTR endocytosis.
X
ABCC7 p.Ser737Ala 24727471:287:240
status: NEW288 Parental CFBE41o-cells were transfected with WT-CFTR or the CFTR-S737A mutant.
X
ABCC7 p.Ser737Ala 24727471:288:65
status: NEW308 The S737A mutation attenuated CFTR endocytosis and increased the plasma membrane abundance of CFTR (Fig. 8).
X
ABCC7 p.Ser737Ala 24727471:308:4
status: NEW331 Experiments demonstrating that compared with WT-CFTR the phosphorylation-deficient mutant CFTR S737A has increased plasma membrane abundance at steady-state and decreased endocytosis in CFBE41o-cells.
X
ABCC7 p.Ser737Ala 24727471:331:95
status: NEW332 Parental CFBE41o-cells were transfected with the WT-CFTR (WT) or the CFTR-S737A mutant (S737A), and cells were cultured on collagen-coated tissue culture plates for 48 h to form monolayers.
X
ABCC7 p.Ser737Ala 24727471:332:74
status: NEWX
ABCC7 p.Ser737Ala 24727471:332:88
status: NEW334 Immunoblots (A) and summaryofdata(B)demonstratingthattheS737AmutationdecreasedCFTRendocytosis.TheamountofbiotinylatedWT-CFTRorCFTR-S737Aremainingafter the GSH treatment at 4 &#b0;C without warming to 37 &#b0;C was considered background and was subtracted from the amount of biotinylated WT-CFTR or CFTR-S737A remaining after warming to 37 &#b0;C.
X
ABCC7 p.Ser737Ala 24727471:334:303
status: NEW335 Endocytosis of WT-CFTR or CFTR-S737A was calculated after subtracting the background (see above) and was expressed as the percent of WT-CFTR or CFTR-S737A remaining biotinylated before and after warming to 37 &#b0;C. WT-CFTR and CFTR-S737A was detected with antibody CFF596.
X
ABCC7 p.Ser737Ala 24727471:335:31
status: NEWX
ABCC7 p.Ser737Ala 24727471:335:149
status: NEWX
ABCC7 p.Ser737Ala 24727471:335:234
status: NEW338 The whole cell lysate (WCL) expression of WT-CFTR or CFTR-S737A mutant detected with antibody CFF596 was used as a loading control to account for small differences in the expression levels of the transiently transfected proteins.
X
ABCC7 p.Ser737Ala 24727471:338:58
status: NEW
PMID: 26079370
[PubMed]
Malik FA et al: "Sphingosine-1-Phosphate Is a Novel Regulator of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Activity."
No.
Sentence
Comment
123
(F) S1P fails to inhibit iodide efflux in na&#ef;ve BHK cells transiently transfected with a plasmid encoding a mutated CFTR containing a serine-to-alanine substitution at amino acid 737 (CFTRS737A ).
X
ABCC7 p.Ser737Ala 26079370:123:138
status: NEW